PLG and COVID-19: These results are presented for COVID-19 patients, non-COVID-19 patients and healthy controls to enable a comparison to be made of the severity of fibrinolysis resistance present, given the prominence in the recent literature on fibrinolysis resistance in COVID-19 including novel trials of t-PA and plasminogen administration [17, 18, 36].